Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 Maio 2024 - 5:05PM
Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’
digital channels, today announced that, on May 1, 2024, the
Compensation Committee of Cardlytics’ Board of Directors granted an
aggregate of 38,500 restricted stock units of Cardlytics to five
newly hired employees. The restricted stock units were granted as
material inducements to employment with Cardlytics in accordance
with Nasdaq Listing Rule 5635(c)(4) and were granted under the
Cardlytics, Inc. 2022 Inducement Plan (the “2022 Inducement Plan”).
The five newly hired employees were granted restricted stock
units on one of two different vesting schedules. For some of the
grant recipients, 100% of the restricted stock units shall vest on
the first anniversary of the grant date, subject to the employees’
continuous service with Cardlytics through the vesting date. For
the other grant recipients, 50% of the restricted stock units shall
vest on the first anniversary of the grant date, and the remaining
50% shall vest quarterly over the subsequent 12 months, subject to
the employees’ continuous service with Cardlytics through the
vesting date. The restricted stock units are subject to the terms
and conditions of the 2022 Inducement Plan.
About Cardlytics
Cardlytics (NASDAQ: CDLX) is a digital advertising platform. We
partner with financial institutions to run their rewards programs
that promote customer loyalty and deepen relationships. In turn, we
have a secure view into where and when consumers are spending their
money. We use these insights to help marketers identify, reach, and
influence likely buyers at scale, as well as measure the true sales
impact of marketing campaigns. Headquartered in Atlanta, Cardlytics
has offices in Menlo Park, Los Angeles, New York, and London. Learn
more at www.cardlytics.com.
Contacts:
Public Relations:pr@cardlytics.com
Investor Relations:ir@cardlytics.com
Cardlytics (NASDAQ:CDLX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Cardlytics (NASDAQ:CDLX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025